U.S. antitrust enforcers should consider blocking a bid by Compass, the nation’s largest residential real estate broker, to acquire rival Anywhere Real Estate, amid a housing shortage, two Democratic ...
Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depression (TRD) ...
Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results